Skip to search.
 All Ordinaries Up1.29%

More On BIT.AX



News & Info


Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates



Biotron Ltd (BIT.AX)

0.06 Down 0.00(1.75%) 9 Oct 16:10
ProfileGet Profile for:
Biotron Ltd
56 Delhi Road
Suite 19
North Ryde, NSW 2113
Australia - Map
Phone: 61 2 9805 0488
Fax: 61 2 9805 0688

Index Membership:N/A
Full Time Employees:4

Business Summary 

Biotron Limited, a biotechnology company, engages in the development and commercialization of novel small molecule antiviral therapeutics targeting Hepatitis C virus (HCV) and HIV-1 in Australia. The company's lead antiviral drug is BIT225, a viroporin inhibitor that has completed Phase II clinical trial for the treatment of HCV, HIV, and HIV/HCV infections. It also has a portfolio of clinical and preclinical antiviral programs developing drugs targeting HCV, HIV, and dengue and influenza viruses. Biotron Limited is based in North Ryde, Australia.

Key Statistics

Company Websites 
Home Page
Search Yahoo!7 for:
More on Biotron Ltd

Key Executives 
Dr. Michelle Miller BSc, MSc, Ph.D., GCertAppFin (Finsia),
Managing Director and Exec. Director
Mr. Peter James Nightingale BEc, CA, 58
Company Sec.
Amounts are as of 31/12/2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.
View Insiders